Global Endoscopic Imaging Market

The Endoscopic Imaging Market size was valued at USD 36.64 Billion in 2025 and the total Endoscopic Imaging revenue is expected to grow at a CAGR of 7.2% from 2026 to 2032, reaching nearly USD 59.6 Billion.

Endoscopic Imaging Market Overview:

Endoscopy is a type of imaging technology used to diagnose various infections and diseases. This technology has proven to be useful in reducing post-operative complications. Endoscopic imaging is growing beyond traditional white light endoscopy. It is a minimally invasive imaging technique used to diagnose various infections and diseases.

This technology has simplified surgical treatments by requiring fewer invasive procedures. Endoscopy innovation has been a new trend in the endoscopic imaging market, with the introduction of next-generation endoscopy visualization systems. Next-Gen endoscopic imaging is a low-cost, minimally invasive procedure that does not leave patients with post-surgery complications or visible scars on their bodies. It allows patients to be discharged from the hospital or surgery center immediately following the imaging procedure, reducing their hospital stay.

The global demand for the endoscopic imaging market is increasing due to growing incidences of chronic diseases such as cancer in the geriatric population as a result of changing lifestyles and eating habits, as well as advanced technological innovations in the field of endoscopy, which drive the endoscopic imaging market growth.

There are numerous advanced imaging technologies available that aim to improve visualization of the vascular network and mucosal surface texture, thereby improving tissue characterization, differentiation, and diagnosis. In addition, less scarring, a lower risk of infection, and shorter hospital stay benefit market growth. However, the global endoscopic imaging market is hampered by high pricing and a scarcity of skilled surgeons and technicians.

To know about the Research Methodology :- Request Free Sample Report

Endoscopic Imaging Market Dynamics:

Endoscopic Imaging Market Drivers

Medical Image Capturing Software Is Critical in the Field of Gastroenterology

Endoscopy is a common non-surgical procedure used primarily by gastroenterologists to examine a patient's digestive tract carefully. While endoscopy can be used to study other internal organs and even blood vessels, it is most commonly used to detect and diagnose digestive tract problems! Endoscopy can also be used to collect tissue samples for biopsy and, on occasion, to perform minor therapeutic procedures. Endoscopy reporting must include information about the biopsy or treatment performed. Thus, the significance of comprehensive and extensive endoscopy reports cannot be overstated! This is where the need for endoscopic imaging software comes into play. These aspects are expected to drive the growth of the endoscopic imaging market.

Increasing need for endoscopy to identify and treat specific diseases

Endoscopy procedures are minimally invasive surgeries that use small tubes, tiny cameras, and surgical instruments to be performed through one or more small incisions. Endoscopy imaging procedures have several advantages, including less pain, a shorter or no hospital stay, and fewer complications related to pre and post-surgery care.

These procedures are less expensive, more effective, and safer than traditional open surgeries. Moreover, these procedures are covered by health insurance providers in wealthy countries such as the United States, Canada, the United Kingdom, Germany, Australia, and a few Middle Eastern countries such as the United Arab Emirates. These aspects contribute to patients' and physicians' strong preference for the endoscopic imaging market. The United States performs nearly 11.2 million colonoscopies, 6.2 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasound examinations, and 169,500 endoscopic retrograde cholangiopancreatography procedures each year.

Endoscopy imaging is increasingly being used to diagnose and treat a variety of major diseases, including cancer, orthopedic disorders, neurological disorders, and gastroesophageal reflux disease (GERD). The GLOBOCAN estimated that 457 965 new cancer cases were diagnosed in the UK in 2023, with this figure expected to rise to 27.5 million by 2040 (a 61.8% increase). As a result, the number of cancer surgeries will increase significantly: for example, approximately 82% of cancer cases are likely to require surgery. The rising incidence of target diseases such as cancer, neurodegenerative, infectious, immune, metabolic, and cardiovascular diseases is expected to increase the demand for endoscopic imaging procedures, boosting the endoscopic imaging market growth in the forecast years.

Endoscopic Imaging Market Restraints

A scarcity of trained physicians and endoscopists

Endoscopy physicians and surgeons are in short supply worldwide. This shortage of trained endoscopy professionals is also expected in the Asia Pacific, Latin America, and Europe (excluding the UK, where training has been provided for nurse endoscopists for the last 10 years by the United Kingdom Central Council for Nursing, Midwifery, and Health). Endoscopy procedures must be performed by trained professionals in order to prevent the spread of infections in endoscopy facilities.

The global shortage of skilled endoscopy physicians and nurses is expected to have a negative impact on the number of endoscopy procedures performed each year as well as on the endoscopic imaging market. To address this concern, a few market participants, such as Olympus, have established training centers. The company has 22 endoscopy training centers in Asia alone. These initiatives will raise awareness of the most recent technological advances in the field of endoscopy while also increasing the number of trained endoscopy professionals.

Endoscopic Imaging Market Opportunity

Growing healthcare sector in the developing countries

Brazil, Russia, India, China, and South Africa (BRICS) have some of the world's fastest-growing economies. According to the World Economic Forum, emerging economies will account for roughly one-third of global healthcare expenditure in 2025. Because India and China have more than half of the world's population, these countries have the highest number of patents.

The rising cancer burden, rapid improvements in healthcare infrastructure, the rapid growth of medical tourism, and the presence of flexible regulation in these countries all encourage endoscopy equipment manufacturers to expand their presence in emerging endoscopic imaging markets. Several endoscopy equipment manufacturers are currently establishing facilities in the Asia Pacific, the Middle East, and Latin America. Stryker and KARL STORZ have already established manufacturing and R&D facilities in these countries. Additionally, endoscopic imaging market saturation in developed regions such as North America and Europe will force endoscopy equipment manufacturers to concentrate their efforts in emerging markets in the forecast years.

Technological advancement is boosting the endoscopic imaging market

Increasing preference among medical professionals to use technologically advanced endoscopy imaging devices equipped with high-definition cameras and light sources to assist physicians in analyzing internal organs of interest drives the endoscopic imaging market. The preference for minimally invasive surgical procedures over traditional surgeries to reduce hospital stay and post-procedure complications is expected to fuel demand for endoscopic imaging devices. As a result, factors such as increased patient satisfaction, increased economic viability, and shorter hospital stays are expected to increase demand for minimally invasive endoscopic interventions in the forecast years, accelerating endoscopic imaging market growth.

During the forecast period, technological advancement to develop innovative endoscopic imaging devices is also expected to accelerate endoscopic imaging market growth. The leading manufacturers are constantly working to develop advanced endoscopic solutions for the better treatment and diagnosis of a variety of chronic diseases. For example, Fujifilm Holdings Corporation announced the commercial launch of the ELUXEO 7000X endoscopic Imaging System in August 2021. During laparoscopic and/or endoluminal imaging procedures, this advanced imaging system allows for real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue.

Endoscopic Imaging Market Segment Analysis:

Based on the Application, The Gastroenterology segment dominated the endoscopic imaging markets in 2025, accounting for 55.7% of revenue. The rising incidence of gastrointestinal diseases in the young, adult, and geriatric populations worldwide is one of the primary factors driving the growth of the gastroenterology segment.

gastrointestinal disorders include dyspepsia, irritable bowel syndrome, and constipation. In addition, gastroesophageal reflux disease is a common type of organic gastrointestinal disorder. The rising prevalence of gastrointestinal diseases, combined with an aging population, is driving the demand for gastrointestinal endoscopy. Gastrointestinal tumors are the world's second leading cause of cancer-related deaths. Endoscopy has proven to be the gold standard for detecting gastrointestinal cancers.

As a result, an increase in endoscopic procedures for the early detection of gastrointestinal cancers is expected to drive the market in the coming years. The vast majority of gastrointestinal stromal tumors begin in the rectum, colon, or esophagus. The majority of people diagnosed with gastrointestinal stromal tumors are over the age of 50.

The market will be driven by the increasing prevalence of these tumors. According to the American Cancer Society (ACS), there will be 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in the United States in 2022. According to the American Cancer Society, the lifetime risk of developing colorectal cancer is approximately one in 23 (4.3%) for men and one in 25 (4.0%) for women. the According to the World Health Organization (WHO), there will be approximately 1.93 million cases of colon and rectum cancer in 2021.

Moreover, due to the rising prevalence of chronic urological diseases such as cancer and tumor, as well as the increasing number of cystoscopy procedures, the urology endoscopy segment is expected to grow at the fastest rate during the forecast years. According to a report published by Cancer Research UK, approximately 10,300 new cases of bladder cancer are diagnosed in the United Kingdom each year, making it the 11th most common cancer in the country. Because cystoscopy is the primary diagnostic procedure for bladder cancer, it is expected to drive segment growth in the forecast years.

Based on the Product, the Visualization Equipment segment accounted for the largest revenue share of 37.5% in the endoscopic imaging market in 2023, owing to their widespread use during endoscopy procedures and increasing application for the visualization and diagnosis of complex disease conditions such as cancer, GI disorders, urinary disorders, and lung disorders. Furthermore, the availability of next-generation endoscopy visualization systems, which allow surgeons to visualize the internal organ of choice with a minimally invasive procedure, is increasing its adoption and indicating a higher share for the segment.

Moreover, the endoscopes segment accounted for a CAGR of 9.4% in the endoscopic imaging market for endoscopy devices during the forecast period.

This rapid growth is attributed to an increase in the number of endoscopic procedures, as well as the widespread use of endoscopes to perform surgeries and biopsies for better diagnosis and treatment. The flexible endoscopes segment dominated the endoscopes segment and accounted for a high revenue share in 2023, owing to its high preference for use by medical professionals and advantages such as safety, increased efficiency, and enhanced ergonomics when compared to rigid endoscopes.

Endoscopic Imaging Market Regional Insights:

North America had the highest revenue share of 43.3% in the market for endoscopic imaging market in 2025. The rising prevalence of chronic diseases such as cancer, as well as an aging population, are expected to drive the endoscopic imaging market in North America during the forecast period, as are technological innovations and new product launches. Colorectal cancer is the third leading cause of cancer-related deaths in men and women, and the second leading cause of cancer deaths in the combined population in the United States, according to the American Cancer Society. It is estimated that the country will have 107,180 new cases of colon cancer and 44,860 new cases of rectal cancer in 2025, resulting in 52,590 deaths.

As a result of the high incidence of colorectal cancer, the endoscopic imaging market is driven by its diagnosis and treatment. Additionally, new product launches in the studied market will boost the endoscopic imaging market in the region. For example, in October 2023, FUJIFILM Healthcare Americas Corporation will release the El-740D/S dual-channel endoscope for both upper and lower gastrointestinal applications.

In addition, in July 2020, FUJIFILM Medical Systems U.S.A., Inc. launched the ELUXEO Surgical System, which is expected to provide unparalleled visualization while performing both flexible and rigid endoscopy from a single tower. The introduction of new products into the market will help the endoscopic imaging market to grow. Moreover, Ambu Inc. received Health Canada clearance for the scope 4 Cysto, an innovative flexible cystoscope platform for urology, in April 2023.

Regulatory approval for products is expected to contribute significantly to endoscopic imaging market growth. Additionally, key initiatives taken by market players such as mergers, acquisitions, and partnerships strengthen their product portfolio in the region, thereby driving the endoscopic imaging market. For example, in November 2023, RoundTable Healthcare Partners' portfolio company, Healthcare Components Group ("HCG"), acquired Endoscopy Development Company ("EDC"), bringing all endoscopy components in both the optical and flexible categories under one roof. As a result, the presence of HCG in the country is increasing, and the country is moving forward.

Moreover, due to the large population and an increasing number of functional gastrointestinal disorder patients in Asia Pacific, the endoscopic imaging market for endoscopy devices is expected to grow at the fastest rate during the forecast years. Additionally, growing demand for minimally invasive endoscopic procedures and improved healthcare infrastructure are expected to drive the region's endoscopic imaging market growth. Increasing government initiatives to modernize healthcare facilities and constantly developing a start-up landscape are among the major factors promoting the region's endoscopic imaging market growth.

Endoscopic Imaging Market Recent Industry Developments

Endoscopic Imaging Market Scope: Inquire before Buying

Endoscopic Imaging Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Endoscopic Imaging Market key players

1. Olympus Corporation
2. Karl Storz SE & Co. KG
3. Stryker Corporation
4. Boston Scientific Corporation
5. Fujifilm
6. Medtronic plc
7. Richard Wolf GmbH
8. Cook Medical
9. Smith & Nephew plc
10. Pentax Medical (Hoya Corporation)
11. Johnson & Johnson (Ethicon)
12. B. Braun Melsungen AG
13. Mindray Medical International Limited
14. ConMed Corporation
15. Ambu A/S
16. Arthrex Inc.
17. Zimmer Biomet Holdings Inc.
18. Cantel Medical (STERIS)
19. Micro-Tech (Nanjing) Co.Ltd.
20. Laborie Medical Technologies
21. Echosens
22. CapsoVision Inc.
23. IntroMedic Co.Ltd.
24. Huger Medical Instrument Co.Ltd.
25. Shaili Endoscopy